Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 16 studies | 40% ± 17% | |
| interneuron | 5 studies | 27% ± 10% | |
| oligodendrocyte precursor cell | 5 studies | 22% ± 4% | |
| GABAergic neuron | 5 studies | 26% ± 5% | |
| glutamatergic neuron | 4 studies | 35% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 8450.38 | 2559 / 2642 | 100% | 378.51 | 703 / 705 |
| adrenal gland | 0% | 0 | 0 / 258 | 13% | 0.77 | 29 / 230 |
| breast | 0% | 0 | 0 / 459 | 4% | 2.97 | 46 / 1118 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.09 | 3 / 80 |
| uterus | 0% | 0 | 0 / 170 | 2% | 0.12 | 11 / 459 |
| pancreas | 0% | 0 | 0 / 328 | 2% | 0.51 | 4 / 178 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.03 | 7 / 504 |
| lung | 0% | 0 | 0 / 578 | 1% | 0.06 | 15 / 1155 |
| ovary | 0% | 0 | 0 / 180 | 1% | 0.17 | 5 / 430 |
| esophagus | 0% | 0 | 0 / 1445 | 1% | 0.02 | 2 / 183 |
| prostate | 0% | 0 | 0 / 245 | 1% | 0.02 | 4 / 502 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.01 | 7 / 901 |
| stomach | 0% | 0 | 0 / 359 | 1% | 0.01 | 2 / 286 |
| thymus | 0% | 0 | 0 / 653 | 1% | 0.02 | 4 / 605 |
| intestine | 0% | 0 | 0 / 966 | 1% | 0.06 | 3 / 527 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.13 | 2 / 406 |
| skin | 0% | 0 | 0 / 1809 | 0% | 0.01 | 2 / 472 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
| GO_0001501 | Biological process | skeletal system development |
| GO_0010001 | Biological process | glial cell differentiation |
| GO_0007155 | Biological process | cell adhesion |
| GO_0007417 | Biological process | central nervous system development |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0045202 | Cellular component | synapse |
| GO_0005576 | Cellular component | extracellular region |
| GO_0072534 | Cellular component | perineuronal net |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0005540 | Molecular function | hyaluronic acid binding |
| Gene name | NCAN |
| Protein name | Neurocan Neurocan core protein (Chondroitin sulfate proteoglycan 3) |
| Synonyms | CSPG3 NEUR |
| Description | FUNCTION: May modulate neuronal adhesion and neurite growth during development by binding to neural cell adhesion molecules (NG-CAM and N-CAM). Chondroitin sulfate proteoglycan; binds to hyaluronic acid. |
| Accessions | O14594 K7EKF8 ENST00000252575.11 ENST00000588231.1 |